Showing 24 of 24 results
Number of displayed results:
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in glutamatergic neuronHomo sapiens glutamatergic neuron, 7 days post differentiation genetically modified (episome) using transient transfection, (insertion) using TALEN inserting M. musculus Neurog2Lab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in activated T-helper 17 cellMus musculus strain C57BL/6NJ activated T-helper 17 cell genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in glutamatergic neuronHomo sapiens glutamatergic neuron, 14 days post differentiation genetically modified (episome) using transient transfection, (insertion) using TALEN inserting M. musculus Neurog2 originated from WTC11Lab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in WTC11Homo sapiens WTC11 genetically modified (episome) using transient transfection, (insertion) using TALEN inserting M. musculus Neurog2Lab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in pancreas organoidHomo sapiens organoid with pancreatic ductal adenocarcinoma; pancreas genetically modified (episome) using transient transfectionElements selection method: accessible genome regions, histone modificationsLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in pancreas organoidHomo sapiens organoid with pancreatic ductal adenocarcinoma; pancreas genetically modified (episome) using transient transfectionElements selection method: accessible genome regions, histone modifications, DNase hypersensitive sitesLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in pancreas organoidHomo sapiens organoid with pancreatic ductal adenocarcinoma; pancreas genetically modified (episome) using transient transfectionElements selection method: accessible genome regions, histone modificationsLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in pancreas organoidHomo sapiens organoid with pancreatic ductal adenocarcinoma; pancreas genetically modified (episome) using transient transfectionElements selection method: accessible genome regions, histone modifications, DNase hypersensitive sitesLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in K562Single human gDNA fragments and concatenated pairs of such fragments were tested for their enhancer activity with eSTARR-seq. The RNAs derived from the transfected plasmids were sequenced and reported here.Elements selection method: transcription start sitesLab: Haiyuan Yu, CornellProject: ENCODE
- STARR-seq in K562Human gDNA fragments were selected based on DHS data, GRO-cap data, and/or histone marks in K562 cells and tested for their enhancer activity with eSTARR-seq. The RNAs derived from the transfected plasmids were sequenced and reported here.Elements selection method: DNase hypersensitive sites, transcription start sites, chromatin statesLab: Haiyuan Yu, CornellProject: ENCODE
- STARR-seq in K562Human gDNA fragments were selected based on DHS data, GRO-cap data, and/or histone marks in K562 cells and tested for their enhancer activity with eSTARR-seq. The RNAs derived from the transfected plasmids were sequenced and reported here.Elements selection method: DNase hypersensitive sites, transcription start sites, chromatin statesLab: Haiyuan Yu, CornellProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 12 hoursLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 12 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 8 hoursLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 8 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 4 hoursLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 1 hourLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 1 hour
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfectionLab: Tim Reddy, DukeProject: GGR
- STARR-seq in MCF-7Homo sapiens MCF-7 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in HCT116Homo sapiens HCT116 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in SH-SY5YHomo sapiens SH-SY5Y genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in HepG2Homo sapiens HepG2 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE